Bybee A, Styles J A, Beck S L, Blackburn D
ICI Central Toxicology Laboratory, Macclesfield, Cheshire, U.K.
Cancer Lett. 1990 Jul 16;52(2):95-100. doi: 10.1016/0304-3835(90)90250-2.
Liver hyperplasia was induced in rats by daily administration of methylclofenapate (25 mg/kg by gavage). An increase in the incidence of colchicine-arrested metaphases was observed with peaks occurring at 40 h (1.3%), 64 h (6.4%) and 84 h (6.8%) after the start of treatment. This response contrasted with the much larger (21.3%) peak in arrested metaphases at 36 h after partial hepatectomy, but was still unexpectedly large in comparison with the S-phase response to methylclofenapate reported in a previous study. Progressive hypertrophic histopathological changes were apparent during the whole course of treatment.
通过每日灌胃给予大鼠甲基氯苯那酯(25毫克/千克)诱导肝脏增生。观察到秋水仙碱阻断中期的发生率增加,在治疗开始后40小时(1.3%)、64小时(6.4%)和84小时(6.8%)出现峰值。这种反应与部分肝切除术后36小时阻断中期的大得多的峰值(21.3%)形成对比,但与先前研究中报道的甲基氯苯那酯的S期反应相比仍然出乎意料地大。在整个治疗过程中,渐进性肥大的组织病理学变化明显。